Lipid mediators of inhalation exposure-induced pulmonary toxicity and inflammation

Inhal Toxicol. 2024 Feb;36(2):57-74. doi: 10.1080/08958378.2024.2318389. Epub 2024 Feb 29.

Abstract

Many inhalation exposures induce pulmonary inflammation contributing to disease progression. Inflammatory processes are actively regulated via mediators including bioactive lipids. Bioactive lipids are potent signaling molecules involved in both pro-inflammatory and resolution processes through receptor interactions. The formation and clearance of lipid signaling mediators are controlled by multiple metabolic enzymes. An imbalance of these lipids can result in exacerbated and sustained inflammatory processes which may result in pulmonary damage and disease. Dysregulation of pulmonary bioactive lipids contribute to inflammation and pulmonary toxicity following exposures. For example, inhalation of cigarette smoke induces activation of pro-inflammatory bioactive lipids such as sphingolipids, and ceramides contributing to chronic obstructive pulmonary disease. Additionally, exposure to silver nanoparticles causes dysregulation of inflammatory resolution lipids. As inflammation is a common consequence resulting from inhaled exposures and a component of numerous diseases it represents a broadly applicable target for therapeutic intervention. With new appreciation for bioactive lipids, technological advances to reliably identify and quantify lipids have occurred. In this review, we will summarize, integrate, and discuss findings from recent studies investigating the impact of inhaled exposures on pro-inflammatory and resolution lipids within the lung and their contribution to disease. Throughout the review current knowledge gaps in our understanding of bioactive lipids and their contribution to pulmonary effects of inhaled exposures will be presented. New methods being employed to detect and quantify disruption of pulmonary lipid levels following inhalation exposures will be highlighted. Lastly, we will describe how lipid dysregulation could potentially be addressed by therapeutic strategies to address inflammation.

Keywords: Inhalation; bioactive lipids; exposure; inflammation resolution; pro-inflammation; pulmonary disease; specialized pro-resolving mediators.

Publication types

  • Review

MeSH terms

  • Ceramides
  • Humans
  • Inflammation / chemically induced
  • Inflammation Mediators / metabolism
  • Inhalation Exposure / adverse effects
  • Lung Diseases* / chemically induced
  • Metal Nanoparticles*
  • Silver

Substances

  • Silver
  • Ceramides
  • Inflammation Mediators